drugset / Trial / NCT05149651

Efficacy of Totalfill® and ProRoot MTA® as Pulpotomy Agent in Primary Molars

NCT05149651

Phase 4 Completed 36 enrolled University Ghent
RandomizedParallel-groupDouble-blindTreatment

Summary

An experimental prospective double-blind, randomized clinical trial (RCT) with parallel design. To evaluate the outcome of using 2 pulpotomy agents: Totalfill® as study group and mineral trioxide aggregate (MTA®) as a control.

Timeline

Start
2017-01-01
Primary completion
2018-12-31
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator ProRoot White MTA® Unknown
Subject bioceramic sealer Unknown

Indications